Chris Heery

Chief Medical Officer
Precision BioSciences
Chris Heery
'- Chris Heery, MD, is the Chief Medical Officer at Precision BioSciences where he has led the clinical program for allogeneic CAR T since its inception in 2019. Prior to joining Precision, Dr. Heery served as CMO of Bavarian Nordic where he oversaw clinical development programs for its immune-oncology and infectious diseases portfolios. Prior to this, he was Head of the Clinical Trials Group of the Laboratory of Tumor Immunology and Biology at NCI. He joined the NCI as a Medical Oncology Fellow in 2009 and transitioned to a permanent position in 2012 as the clinical lead for the Laboratory of Tumor Immunology and Biology and an Adjunct Appointment in the Genitourinary Malignancies Branch with a focus on translation of novel immunotherapies for the treatment of cancer. He is board certified in Medical Oncology and Internal Medicine

Sessions

No data was found